Cargando…
Central-type primitive neuroectodermal tumor of the uterus: Case report of remission of stage IV disease using adjuvant cisplatin/etoposide/bevacizumab chemotherapy and review of the literature
• Bevacizumab was an effective agent in one case of advanced uterine PNET. • VEGF was expressed by the tumor, supporting a mechanism for effectiveness. • Cisplatin/etoposide/bevacizumab should be further studied in clinical trials. • Patient remains disease-free forty-eight months following interven...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688884/ https://www.ncbi.nlm.nih.gov/pubmed/26793768 http://dx.doi.org/10.1016/j.gore.2015.09.002 |